EIC Accelerator funds VBL as it approaches the final enrollm...
EIC Accelerator funds VBL as it approaches the final enrollment phase of its key product candidate, ofra-vec (VB-111), for ovarian cancer. The CEO perceives this investment as acknowledgment of the potential ofra-vec offers to patients and the current critical need in ovarian cancer therapies.
![](https://static.futunn.com/upload/news_img/VCG41N157284421-9e53415da29359401cde283f923bb2df.jpg?_=1629714065344)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment